The story of the Beta Cells and their role in autoimmune Type 1 Diabetes
A Beta way - Type 1 diabetes
Bekijk meer
StartpaginaArtikelen
Voor zorgverleners
FLUNITY-HD Study Demonstrated the Superior Protection Beyond Flu of High-Dose Flu Vaccine vs Standard-Dose Flu Vaccine*
FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1
Bekijk meer
EVEREST study highlights
First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.
Bekijk meer
Understanding Disease Modification in Atopic Dermatitis
Understanding Disease Modification in Atopic Dermatitis
Bekijk meer
Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk
People with type 2 diabetes and atherosclerotic cardiovascular disease face a high risk of cardiovascular events, yet many remain undertreated.1 The EASD/ADA 2022 and ESC 2023 guidelines for the management of type 2 diabetes urge early insulin initiation and intensive lipid lowering through a holistic approach. Managing both glycemia and lipids together is key to preventing CV events in people with type 2 diabetes.2,3
Bekijk meer
Understanding Autoimmune T1D & The Value of Early Detection
Autoimmune Type 1 Diabetes (T1D) can be detected through islet autoantibody testing years before symptoms appear.1-2 The video here explains how the condition progresses silently through presymptomatic stages, with beta cell destruction occurring long before symptom onset and clinical diagnosis.4-8
Bekijk meer
When a Child Gets Autoimmune Type 1 Diabetes
Parent's experiences of stage 3 diagnosis of T1D.
Bekijk meer
Sleep and QOL: the full impact on patients coping with the burden of AD
Understanding the full scope of AD—the unseen burden on patients.
Bekijk meer
Real-life stories from people living with autoimmune T1D
The progression of autoimmune type 1 diabetes (T1D) is gradual, often detectable months or even years before symptoms arise.1–3 Through proactive screening, we can identify the condition well in advance.3 Meet our ambassadors living with autoimmune T1D and discover the risk factors to look out for when considering who to screen.
Bekijk meer